Christopher Causey, Director at UNITED THERAPEUTICS Corp (UTHR), sold 1,560 shares at $118.00 ($184K) on 2018-09-06, disclosed to the SEC on 2018-09-07.
Seasonal sale ($184k) by Director — this insider has traded UTHR in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.00 | 810 | $96K | 51.8% |
| 2 | $118.48 | 750 | $89K | 48.2% |
| Total | $118.23 avg | 1,560 | $184K | 100% |
| Filing → |
| UTHR | SELL | 2026-02-25 | $520K | — | Filing → |
| UTHR | SELL | 2026-01-06 | $510K | — | Filing → |
| UTHR | SELL | 2026-01-05 | $500K | — | Filing → |